Literature DB >> 27080426

Common variant in PTK2B is associated with late-onset Alzheimer's disease: A replication study and meta-analyses.

Ya-Qing Li1, Meng-Shan Tan1, Hui-Fu Wang1, Chen-Chen Tan1, Wei Zhang2, Zhan-Jie Zheng3, Ling-Li Kong3, Zi-Xuan Wang1, Lin Tan4, Teng Jiang5, Lan Tan6, Jin-Tai Yu7.   

Abstract

Emerging evidence indicates that protein tyrosine kinase 2β (PTK2B) is involved in the pathogenesis of Alzheimer's disease (AD). Recently, a large, two-stage meta-analysis of genome-wide association study (GWAS) confirmed that PTK2B was correlated with an increased risk of AD in Caucasian populations. The aim of this study was to investigate the association between PTK2B polymorphism rs28834970 and the risk of LOAD in a Han Chinese population. A total of 984 sporadic LOAD patients and 1,354 healthy age- and sex-matched control subjects from the Han Chinese population were included in this study. Our results showed no significant differences in the frequency of rs28834970 alleles and genotypes between AD cases and controls. However, meta-analysis of 82,513 individuals confirmed that rs2883490 within PTK2B increased the risk of LOAD (OR=1.09, 95%CI=1.07-1.12). Additionally, when these data were stratified by APOEε4 status, the difference of allele frequency was evident in APOEε4 carriers (P=0.027, OR=1.423, 95%CI=1.041-1.945), and positive associations were also observed under an additive model in APOEε4 carriers (P=0.041, OR=1.384, 95%CI=1.014-1891). In summary, our study provides that PTK2B polymorphism (rs28834970) could modify the risk of LOAD, and PTK2B polymorphism (rs28834970) and APOE may interact to increase LOAD risk in a Han Chinese population.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Association study; Meta-analysis; PTK2B; rs28834970

Mesh:

Substances:

Year:  2016        PMID: 27080426     DOI: 10.1016/j.neulet.2016.04.020

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.

Authors:  Chunyu Zhang; Riletemuer Hu; Guohua Zhang; Yan Zhe; Baolige Hu; Juan He; Zhiguang Wang; Xiaokun Qi
Journal:  J Mol Neurosci       Date:  2019-07-25       Impact factor: 3.444

Review 2.  The relationship of early- and late-onset Alzheimer's disease genes with COVID-19.

Authors:  Seda Sirin; Serap Nigdelioglu Dolanbay; Belma Aslim
Journal:  J Neural Transm (Vienna)       Date:  2022-04-16       Impact factor: 3.850

3.  Re-thinking Alzheimer's disease therapeutic targets using gene-based tests.

Authors:  Man Ki Kwok; Shi Lin Lin; C Mary Schooling
Journal:  EBioMedicine       Date:  2018-10-09       Impact factor: 8.143

4.  Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy.

Authors:  A Harrison Brody; Sarah Helena Nies; Fulin Guan; Levi M Smith; Bandhan Mukherjee; Santiago A Salazar; Suho Lee; Tu Kiet T Lam; Stephen M Strittmatter
Journal:  Mol Neurodegener       Date:  2022-05-03       Impact factor: 18.879

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.